AIVC for drug research
Customized datasets, predictive vertical models and an oncology-first foundation-model program, connected through experiments and validation.
Explore AIVC applications
We develop proteomics-rich AI virtual cells, deliver research services and advance clinical diagnostics—connecting protein measurements to discovery and laboratory applications.
Customized datasets, predictive vertical models and an oncology-first foundation-model program, connected through experiments and validation.
Explore AIVC applicationsQuantitative, spatial, plasma, targeted and multi-omics workflows, with study design and data analysis.
View research servicesMass-spectrometry laboratory products and thyroid-nodule proteomics, including LMDx IGF-I and ThyroProt.
Explore clinical diagnosticsProteomic profiles across 18 breast-cancer cell lines.
Temporal protein measurements capturing cellular responses.
Drugs and drug combinations in the published response dataset.
Sun et al., Nature (2026) · Study-specific experimental dataset.
Proteins form the machinery of the cell. Their abundance, interactions and location help describe how that machinery responds.
A useful virtual cell needs evidence matched to the decision: the intervention, dose, time, tissue context and measured outcome. We prioritize informative protein-state experiments and integrate RNA, images and biological knowledge.
Explore the data strategyTurn mass-spectrometry spectra into interpretable protein evidence with AI-supported analysis.
Explore spectral AILearn how protein states change after intervention, and evaluate drug-response and combination tasks.
Read ProteinTalksConnect protein measurements to tissue location, cells and organelles through image-guided sampling.
Read the spatial methodCombine complementary molecular layers with biological priors and function-centered model design.
Read the data frameworkPublished temporal modeling and spatial measurement are foundations for our developing integrated time–space framework.
Connect purpose-designed experiments, scenario-specific predictions and reusable cellular representations.
Explore applicationsControlled perturbation proteomics and relevant multi-omics, with quality control and functional readouts.
Fine-tune for a defined drug-research task and evaluate predictions independently.
An oncology-first development program, with new data guiding expansion to further biological contexts.
FAXP for spatial protein measurements. OmniProt for plasma and serum enrichment.
A nanoparticle-based research kit for enriching low- and medium-abundance proteins before mass-spectrometry analysis.
Explore OmniProtTissue-expansion and sample-preparation workflows connect protein measurements with tissue, cell and organelle location.
Explore FAXPResearch kits complement our AIVC partnerships and measurement services.
Explore our diagnostic products and translational proteomics capabilities.
Insulin-like growth factor I, measured by LC–MS/MS.
A mass-spectrometry-based test kit for IGF-I quantification, supporting laboratory assessment of growth and endocrine biology.
Protein evidence for thyroid-nodule assessment.
Quantitative proteomics and AI for investigating benign and malignant thyroid nodules, including tissue and fine-needle-aspiration research.
Product-specific intended use and availability are separate from AIVC research predictions. Contact our clinical team for current product documentation.
Define the intervention, context and decision. Build the evidence together.